Feed ATOS
AT

Atossa Therapeutics, Inc. ATOS · NASDAQ

$2.60 -4.41% (-$0.12)

Market cap
$27.1M
Enterprise value
$1.05M
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/FCF
-
EV/EBITDA
-
ROIC
-146.3%
Bruto marža
-
Neto marža
-
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
-
Beta
1.28
Free float
98.5%

O podjetju

Atossa Therapeutics, Inc. (ATOS) is a biotechnology company focused on the development and commercialization of drugs and therapies in the fields of oncology and women's health. The company concentrates on researching new medications and diagnostic methods aimed at the prevention and treatment of various types of cancer, including breast cancer. Atossa Therapeutics also develops innovative treatments and therapeutic approaches to enhance women's health. Shares of Atossa Therapeutics, Inc. (ATOS) can be an interesting choice for investors tracking the biotechnology sector and the development of drugs and therapies.

Sector

Healthcare

Industry

Biotechnology

CEO

Steven C. Quay

Employees

16

Headquarters

Seattle

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.